The Latest Breaking News from FDA

Doctors, clinics and telehealth providers across the country are scrambling to figure out how they will continue to provide the most common type of abortion after a federal appeals court imposed new restrictions on a key abortion medication

The decision comes shortly after an appeals court left numerous restrictions on abortion pill access in place.

It’s not the FDA’s job to tell doctors what to do.

WASHINGTON — Attorney General Merrick Garland said the Biden administration will ask the U.S. Supreme Court to protect the availability of a widely used abortion pill after a federal appeals court cleared the way for new restrictions to take effect Friday.

The Justice Department is seeking emergency relief from the U.S. Supreme Court in a Texas case involving limited access to the abortion drug mifepristone.

Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.

Although inflation has shown signs of easing, it remains elevated. Therefore, the possibility of further rate hikes remains. As fears of a recession rise, investors may consider buying fundamentally strong stocks NetScout Systems (NTCT), Central Puerto (CEPU), and Vanda Pharmaceuticals (VNDA), trading at discounts to their peers. Keep reading….

Court upheld part of a Texas judge's ruling halting FDA decision allowing mifepristone to be distributed by mail

A federal appeals court partly granted the Biden administration’s request to put on hold a Texas court ruling overturning FDA approval of the abortion pill, but allowed restrictions that were lifted since 2016 to be reinstated.

Plus: New developments in the Texas abortion drug ruling, fallout from the Riley Gaines event at SFSU, and more...

At the heart of the latest battle over abortion access is a federal judge’s ruling that cites concern about the mental health of women who choose to end their pregnancies.